JSW Tinplate
  • At the forefront of benefiting Patients
    To make disease management easier and painless for patients and healthcare professionals
  • Concentrated R&D and
    in critical therapies
    Our R&D Team has a deep focus on innovations in injectables and has an array of first-in-the-market formulations, dosages and re-engineered delivery systems
  • Ideas pursued.
    Breakthroughs delivered.
    We develop high response differentiated injectables through our platform technology with a clear focus on ease-of-use and patient compliance
  • VIRALEX
    DCGI has Approved Viralex (Inosine Pranobex) for restricted emergency use as an add-on therapy for the treatment of mild to moderate COVID-19 in India.

    Viralex is an immunomodulatory drug with broad spectrum Antiviral Action

50 years of excellence in Pain Management and Critical Care

More
25 Nov 2019
10 Mar 2023 - 11 Mar 2023
17 Feb 2023 - 19 Feb 2023
23 Dec 2022
24 Nov 2022 - 26 Nov 2022
21 Oct 2022